PRKAG2-AS1: A Drug Target / Disease Biomarker (G100505483)

Target Name: PRKAG2-AS1

NCBI ID: G100505483

PRKAG2-AS1

Other Name(s): PRKAG2 antisense RNA 1

PRKAG2-AS1: A Drug Target / Disease Biomarker

PRKAG2-AS1 is a protein that is expressed in the brain and has been shown to play a role in the development and progression of various neurological disorders, including Alzheimer's disease. It is also a potential drug target for the treatment of these disorders.

The protein PRKAG2-AS1 is a key component of the brain and is involved in the production of a type of RNA called microRNA (miRNA). MiRNA is a small non-coding RNA molecule that plays a role in regulating gene expression and has been shown to be involved in the development and progression of various neurological disorders.

In the case of Alzheimer's disease, miRNA levels have been shown to be altered in the brains of individuals with the condition. Studies have also shown that inhibiting the activity of PRKAG2-AS1, a protein involved in the production of miRNA, may have therapeutic benefits for the treatment of Alzheimer's disease.

Research has also shown that PRKAG2-AS1 is involved in the regulation of the activity of other proteins that are involved in the development and progression of Alzheimer's disease. These proteins include APP, a protein that is known to contribute to the development of Alzheimer's disease, as well as Tau, a protein that is also involved in the development of the disease.

In addition to its role in the development and progression of Alzheimer's disease, PRKAG2-AS1 has also been shown to play a role in the regulation of brain development and plasticity. This is important because understanding how PRKAG2-AS1 is involved in brain development and plasticity may provide insights into the underlying mechanisms of the disease.

The potential drug target for PRKAG2-AS1 is related to the production and regulation of miRNA. This is because inhibiting the activity of PRKAG2-AS1, a protein involved in the production of miRNA, may have therapeutic benefits for the treatment of Alzheimer's disease and other neurological disorders.

In conclusion, PRKAG2-AS1 is a protein that is involved in the development and progression of various neurological disorders, including Alzheimer's disease. It is also a potential drug target for the treatment of these disorders due to its role in the production and regulation of miRNA. Further research is needed to fully understand the role of PRKAG2-AS1 in the development and progression of Alzheimer's disease and other neurological disorders.

Protein Name: PRKAG2 Antisense RNA 1

The "PRKAG2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PRKAG2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets